Skip to main content
logo
City Therapeutics, Inc. (CTY)
NASDAQ: CTY · Real-Time Price · USD
22.40
+4.40 (24.44%)
At close: Oct 16, 2026, 4:00 PM EDT
22.15
-0.25 (-1.12%)
After-hours: Oct 16, 2026, 7:58 PM EDT

City Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-87.67-58.51-27.84
Depreciation & Amortization
1.461.170.42
Other Amortization
0.040.02-0.03
Loss (Gain) From Sale of Assets
-0.03-0.03-0.13
Stock-Based Compensation
6.4231.01
Other Operating Activities
7.253.151.56
Change in Accounts Receivable
-3.450.14-1.35
Change in Accounts Payable
4.214.592.54
Change in Unearned Revenue
-5.817.33.96
Change in Other Net Operating Assets
-0.1-2.46-0.52
Operating Cash Flow
-77.67-41.61-20.39
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-3.08-2.41-3.54
Sale of Property, Plant & Equipment
0.030.030.16
Investing Cash Flow
-3.05-2.38-3.38

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Long-Term Debt Issued
-3015
Net Debt Issued (Repaid)
-3015
Issuance of Common Stock
2.160.89-
Other Financing Activities
-0.61-0.04-0.34
Financing Cash Flow
101.0530.86149.44

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Cash Flow
20.33-13.13125.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-80.75-44.02-23.93
Free Cash Flow Growth
---
Free Cash Flow Margin
-563.00%-324.55%-861.34%
Free Cash Flow Per Share
-14.48-9.37-7.03
Levered Free Cash Flow
--24.37-
Unlevered Free Cash Flow
--22.98-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Change in Working Capital
-5.159.584.62
SEC Filings: 10-K · 10-Q